This topic contains 0 replies, has 1 voice, and was last updated by  Pulmonary Fibrosis News Moderator 3 months, 2 weeks ago.

  • Author
    Posts
  • #20208

    Director of Multichannel Content for Pulmonary Fibrosis News, Michael Morale, discusses an Australian study that suggests that antacid therapy may not benefit IPF patients or impact outcomes.

    What are your thoughts about this study and its findings?

You must be logged in to reply to this topic.

Copyright © 2017-2019 All rights reserved.

©2019 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending
or

Log in with your credentials

or    

Forgot your details?

or

Create Account